A Guide for Testifying at Public Hearings and Reaching State Legislators Click Here...


Information Regarding COVID-19 – April 22nd

Posted on April 22, 2020

Facebooktwittermail

Hello Friends and Neighbors,

I would like to provide you with updates regarding the state’s response and COVID-19. Below you can find resources regarding:

  • IRS Economic Impact Payments and Tax Relief Programs

  • Acton taken to prevent the spread of COVID-19 in nursing homes.

  • Guidance maintaining an adequate supply of chronic prescription medication during the COVID-19 pandemic.

  • Protection of Stimulus Payments

I hope all of you are staying home and staying safe.

Department of Social Services

Economic Impact Payments | Internal Revenue Service

Non-Filers: Enter Payment Info Here | Internal Revenue Service

Coronavirus Tax Relief and Economic Impact Payments | Internal Revenue Service

For more information regarding the Department of Social services, please click here.

 

Nursing Home Information

The Governor’s administration began releasing nursing home case statistics recently, and workers continue to share worry about a lack of personal protection equipment. The governor’s administration has worked to create COVID-specific facilities.

On Sunday, the governor announced more Medicaid money for nursing homes to help cover the cost of staff retention bonuses, overtime and shift incentive payments, as well as personal protective equipment and cleaning and housekeeping supplies. He also said the state’s Department of Public Health will be making physical, on-site visits to all of Connecticut’s 215 nursing homes and long-term care facilities to conduct infection control surveys.

 

Guidance Maintaining an Adequate Supply of Chronic Prescription Medication During the COVID-19 Pandemic

The Food and Drug Administration (FDA) has been closely monitoring the medical supply chain in the United States during the COVID-19 pandemic, understanding that it may be impacted, potentially leading to supply disruptions or shortages.

The Department of Consumer Protection’s (DCP) Drug Control Division has been monitoring FDA actions, and cares deeply about the significant impact that this pandemic may have on patient care. The FDA and DCP are doing everything within their authority to help prevent and alleviate shortages. We continue to work with manufacturers, pharmacies, and direct care facilities to reduce and prevent shortages as the COVID-19 situation evolves.

Any shortages, including any related to COVID-19 will be posted on FDA Drug Shortages webpage below:

https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages

Stimulus Money Protection

The Commissioner of the Department of Banking released a statement urging CT financial institutions to not use stimulus checks to pay debts (like overdrafts) owed to them by their members.

“These payments are being issued to ensure that residents have the means to provide for basic necessities, such as food, medicine and housing, during this public health emergency and period of economic hardship. Recognizing that Connecticut financial institutions are receiving many of the payments as direct deposits into the accounts of their customers and members, this guidance is being issued to all such financial institutions.”

X